Enhanced Group has agreed to raise about $15 million through a private stock sale and to acquire a controlling stake in German live-entertainment company Deutsche Entertainment Aktiengesellschaft (DEAG) by issuing shares. The two transactions would bring in cash from investors while adding a major new shareholding in exchange for Enhanced stock.
Both arrangements involve significant share issuance, and the acquisition is a related-party transaction because Enhanced’s controlling shareholder, Apeiron, is among the DEAG shareholders contributing stock.
Key details
-
Private placement: Enhanced will sell 2,109,705 shares of its Class A common stock for $7.11 each, for expected gross proceeds of about $15 million. Placement fees and other expenses will reduce the amount the company receives. Oppenheimer is lead placement agent and Canaccord Genuity is co-placement agent.
-
Related-party participation: Some buyers in the private placement are related to Enhanced, including controlling shareholder Enhanced Holdings, acting through its nominee, Apeiron.
-
DEAG share exchange: Apeiron and four other holders—Apeiron SICAV Limited – Live Opportunities Fund, Apeiron 101, Galaxy Group Funding and B72 Ventures—will contribute DEAG shares representing about 77% of the German company. Enhanced will issue approximately 10,970,230 new shares in return. No cash will be paid for the DEAG shares.
-
Approvals and closing: The private placement is expected to close in one transaction after the required stockholder consent becomes effective and Enhanced distributes an information statement to stockholders who did not consent. Closing remains subject to customary conditions. The agreement also requires Enhanced to obtain specified stockholder approvals; the details of those approvals are not included in the information provided here.
-
Potential warrant dilution: The terms of warrants issued in Enhanced’s June 2026 private placement will be adjusted when the new shares are issued. Their exercise price, currently adjusted to $38.90, will reset to $7.11, and the number of shares issuable under those warrants could increase by as many as 5,747,000. Those are potential shares upon exercise, not shares being issued in the current placement.
-
Resale registration: At closing, Enhanced is to agree to register the private-placement shares and the DEAG-exchange shares for resale. It must file the registration statement within 30 days of closing and use commercially reasonable efforts to have it take effect as soon as possible, subject to deadlines that depend on whether regulators review it. If fewer shares can be registered than requested, any reduction is to be allocated proportionally among the holders.
-
Temporary limit on other share issuance: From the purchase agreement date until 60 days after the resale registration becomes effective, Enhanced has agreed not to issue new securities or file another registration statement, subject to customary exceptions, including securities issued in the DEAG exchange.
-
Independent review of the exchange: Because Apeiron controls Enhanced and is one of the DEAG shareholders, the company’s board formed a committee made up solely of independent, disinterested directors to evaluate and negotiate the exchange. The committee retained its own legal and financial advisers. Its financial adviser, Roth Capital, concluded that the consideration Enhanced would pay was fair to the company from a financial point of view, based on the assumptions and limitations in its opinion.
Plain-English implications
The transactions would add about 13.1 million Enhanced shares through the private placement and DEAG exchange combined, before any additional shares that might be issued if the adjusted warrants are exercised. The exchange would give Enhanced a roughly 77% stake in DEAG, while the private placement would provide cash proceeds before expenses.